EU STAGES SAFETY CHECK ON IBUPROFEN
April 1st, 2012
BY KEITH NUTHALL
A MAJOR European Union (EU) research project is assessing the safety of common anti-inflammatory drugs such as ibuprofen and diclofenac. The 'Standard Care versus Celecoxib Outcome Trial' (SCOT), is being carried out by researchers in the UK, Denmark and the Netherlands, with 6,000 patients and 685 general medical practices participating. They are assessing the side-effects of non-steroidal anti-inflammatory drugs (NSAIDs), notably digestive and heart problems plus blood pressure changes. Notably, the scientists will see whether these are worse ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.